Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sanofi (FR:SAN)
PARIS:SAN
Sanofi (SAN) Stock Price & Analysis
96 Followers
SAN Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€77.39 - €100.16
Previous Close€94.4
Volume437.36K
Average Volume (3M)1.54M
Market Cap
€118.77B
Enterprise Value€127.72B
Total Cash (Recent Filing)$8.71B
Total Debt (Recent Filing)$18.15B
Price to Earnings (P/E)21.9
Beta0.35
Next Earnings
Jul 25, 2024EPS Estimate
€1.64Last Dividend Ex-Date
May 13, 2024Dividend Yield4.02%
Share Statistics
EPS (TTM)4.32
Shares Outstanding1,264,803,301
10 Day Avg. Volume1,882,944
30 Day Avg. Volume1,536,705
Standard Deviation0.06
R-Squared0.21
Alpha0.00738
Financial Highlights & Ratios
Price to Book (P/B)40.36
Price to Sales (P/S)2.39
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit3.97
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€105.49Price Target Upside14.07% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
Sanofi News
Bulls Say, Bears Say
Bulls Say
Financial HealthNet debt to total capital is at 5%, showing strong financial health.
GrowthGrowth is set to be double-digit in 2025 and beyond, making the investment case a highly attractive turnaround story.
New Drug PotentialBeyfortus is a game-changer for the company, potentially making the guidance of exceeding the €10bn revenue mark by 2030 easy to achieve.
Bears Say
EarningsAssuming a now combined 9% decline in adjusted diluted EPS, calculate 2024 implied adjusted diluted EPS guidance of approximately €7.35 relative to 2023’s €8.08.
Financial PerformanceLowered full-year 2024 revenue 1% from €48.3B to €48.0B.
Legal IssuesAbout 75,000 suits filed in state after federal cases tossed.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
12.70% Mutual Funds
15.03% Other Institutional Investors
72.27% Public Companies and
Individual Investors
SAN FAQ
What was Sanofi’s price range in the past 12 months?
Sanofi lowest stock price was €77.39 and its highest was €100.16 in the past 12 months.
What is Sanofi’s market cap?
Currently, no data Available
When is Sanofi’s upcoming earnings report date?
Sanofi’s upcoming earnings report date is Jul 25, 2024 which is in 3 days.
How were Sanofi’s earnings last quarter?
Sanofi released its earnings results on Apr 25, 2024. The company reported €1.78 earnings per share for the quarter, beating the consensus estimate of €1.728 by €0.052.
Is Sanofi overvalued?
According to Wall Street analysts Sanofi’s price is currently Undervalued.
Does Sanofi pay dividends?
Sanofi pays a Annually dividend of €3.76 which represents an annual dividend yield of 4.02%. See more information on Sanofi dividends here
What is Sanofi’s EPS estimate?
Sanofi’s EPS estimate is €1.64.
How many shares outstanding does Sanofi have?
Sanofi has 1,266,362,500 shares outstanding.
What happened to Sanofi’s price movement after its last earnings report?
Sanofi reported an EPS of €1.78 in its last earnings report, beating expectations of €1.728. Following the earnings report the stock price went up 4.47%.
Which hedge fund is a major shareholder of Sanofi?
Currently, no hedge funds are holding shares in FR:SAN
---
Sanofi Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€105.49 (14.07% Upside)
€105.49 (14.07% Upside)
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-1.70%
12-Months-Change
Fundamentals
Return on Equity
7.22%
Trailing 12-Months
Asset Growth
3.29%
Trailing 12-Months
Company Description
Sanofi
Sanofi engages in the research, production and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Human Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes & cardiovascular, established prescription products and generics, together with research, development and production activities. This segment also includes all associates whose activities are related to pharmaceuticals. The Consumer Healthcare segment comprises, for all geographical territories, the commercial operations for its Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development and production activities dedicated to vaccines. The company was founded in 1973 and is headquartered in Paris, France.
---
SAN Company Deck
---
SAN Earnings Call
Q1 2024
0:00 / 0:00
---
SAN Stock 12 Month Forecast
Average Price Target
€105.49
▲(14.07% Upside)
Technical Analysis
Best Analysts Covering SAN
1 Year
1 Year Success Rate
14/18 ratings generated profit
1 Year Average Return
+5.71%
reiterated a buy rating 12 months ago
Copying Dominic Lunn's trades and holding each position for 1 Year would result in 77.78% of your transactions generating a profit, with an average return of +5.71% per trade.
---